DMT1 mutation: response of anemia to darbepoetin administration and implications for iron homeostasis
- 1 July 2006
- journal article
- Published by American Society of Hematology in Blood
- Vol. 108 (1) , 404-405
- https://doi.org/10.1182/blood-2006-02-003962
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Two new human DMT1 gene mutations in a patient with microcytic anemia, low ferritinemia, and liver iron overloadBlood, 2006
- Microcytic anemia and hepatic iron overload in a child with compound heterozygous mutations in DMT1 (SCL11A2)Blood, 2006
- Functional consequences of the human DMT1 (SLC11A2) mutation on protein expression and iron uptakeBlood, 2005
- Analysis of the E399D mutation in SLC11A2Blood, 2005
- Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organsBlood, 2005
- Hepcidin in iron overload disordersBlood, 2005
- Identification of a human mutation of DMT1 in a patient with microcytic anemia and iron overloadBlood, 2005
- Severe hypochromic microcytic anemia caused by a congenital defect of the iron transport pathway in erythroid cellsBlood, 2004
- Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase proteinBlood, 2003
- The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammationJournal of Clinical Investigation, 2002